BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2007
View Archived Issues
Novel agents for treating diabetes and related disorders disclosed in recent patent literature
Read More
New agents with potential in the treatment of cancer disclosed in recent patent literature
Read More
New agents for musculoskeletal and connective tissue disorders disclosed in recent patents
Read More
Deterioration accelerated in amyotrophic lateral sclerosis patients given minocycline
Read More
MenACWY meningitis vaccine well tolerated, immunogenic in infants
Read More
Solvay reports third quarter 2007 results
Read More
Bristol-Myers Squibb advances growth hormone secretagogue to clinical development
Read More
Naryx Pharma completes enrollment in phase IIb clinical trial of Sybryx for chronic sinusitis
Read More
Xenome enters into joint research collaboration with Amylin for novel peptide therapeutics
Read More
Isis and Excaliard enter collaboration to develop antisense drugs for fibrotic diseases
Read More
Valeant completes enrollment of RESTORE2 phase III trial of retigabine for epilepsy
Read More
Xoma presents an update on the company's clinical development plans
Read More
Cyclacel presents an update on clinical development programs
Read More
Sustained improvement in SLE patients seen with belimumab over 2.5 years
Read More
Inhibition of soluble epoxide hydrolase protects against ischemic injury in vivo
Read More
AMT enters agreement with Digna and CIMA for program for late-stage liver cirrhosis
Read More
Pipex Pharmaceuticals enters CRADA to evaluate Coprexa for Huntington's disease
Read More
Israeli Government awards grant to Modigene for hGH-CTP development program
Read More
Fovea and Genzyme Corporation enter research collaboration in ophthalmology
Read More
CSL Behring reaches primary endpoint in IMPACT phase III clinical study of C1-INH
Read More
Osiris reports positive one-year interim results from phase I/II trial of Chondrogen
Read More
FDA accepts for filing UCB's NDA for Vimpat as adjunctive therapy in epilepsy
Read More
FDA accepts for filing UCB's NDA for Vimpat for diabetic neuropathic pain
Read More
FDA advisory committee to review Entereg NDA
Read More
Eisai submits Japanese NDA application for KES-524 for obesity management
Read More
E.U. approves Merck Serono's Cyanokit for cyanide poisoning
Read More